{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "V",
          "position": "1122"
        },
        "variant_string_id": "LRRK2 I1122V"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD). Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain. However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations. In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that mutations in LRRK2 cause PD, leading to increased inclusion body formation and cell death, defining the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used, inclusion body formation and cell death assays, are relevant to the defined disease mechanism of PD caused by LRRK2 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells (Fig. 2A). Wild-type dardarin formed inclusion bodies in approximately 5% of cells but were small compared to the larger and more numerous inclusions seen with mutant protein (25-60% of cells; see also Fig. 6B for quantitative analysis).",
          "judgment": "Yes",
          "reasoning": "The paper included negative (wild-type) controls. Multiple replicates were used, as stated in figure legends and methods: 'Four replicate transfections were used, with at least 50 cells counted per culture.'",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants R1441C, Y1699C, G2019S and I2020T as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Not applicable here",
          "judgment": "No",
          "reasoning": "The paper does not provide OddsPath calculations or sufficient statistical analysis to derive OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper used R1441C, Y1699C, G2019S, and I2020T as controls. Cell counts were performed and statistical significance was evaluated, indicating multiple data points across replicates, though not statistically combined into an OddsPath.",
          "judgment": "N/A",
          "reasoning": "Since the number of benign/pathogenic variants used in the study as controls is more than 11 (R1441C, Y1699C, G2019S, I2020T, kinase-dead variants, etc.)",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The LRRK2 I1122V variant increases inclusion body formation which is related to the disease mechanism of Parkinson's disease. The number of controls is > 10. Therefore, a moderate strength of evidence is assigned."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD). Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain. However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations. In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that mutations in LRRK2 cause PD, leading to increased inclusion body formation and cell death, defining the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used, inclusion body formation and cell death assays, are relevant to the defined disease mechanism of PD caused by LRRK2 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells (Fig. 2A). Wild-type dardarin formed inclusion bodies in approximately 5% of cells but were small compared to the larger and more numerous inclusions seen with mutant protein (25-60% of cells; see also Fig. 6B for quantitative analysis).",
          "judgment": "Yes",
          "reasoning": "The paper included negative (wild-type) controls. Multiple replicates were used, as stated in figure legends and methods: 'Four replicate transfections were used, with at least 50 cells counted per culture.'",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants R1441C, Y1699C, G2019S and I2020T as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Not applicable here",
          "judgment": "No",
          "reasoning": "The paper does not provide OddsPath calculations or sufficient statistical analysis to derive OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper used R1441C, Y1699C, G2019S, and I2020T as controls. Cell counts were performed and statistical significance was evaluated, indicating multiple data points across replicates, though not statistically combined into an OddsPath.",
          "judgment": "N/A",
          "reasoning": "Since the number of benign/pathogenic variants used in the study as controls is more than 11 (R1441C, Y1699C, G2019S, I2020T, kinase-dead variants, etc.)",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The LRRK2 R1441C variant increases inclusion body formation and causes cell death, which is related to the disease mechanism of Parkinson's disease. The number of controls is > 10. Therefore, a moderate strength of evidence is assigned."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD). Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain. However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations. In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that mutations in LRRK2 cause PD, leading to increased inclusion body formation and cell death, defining the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used, inclusion body formation and cell death assays, are relevant to the defined disease mechanism of PD caused by LRRK2 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells (Fig. 2A). Wild-type dardarin formed inclusion bodies in approximately 5% of cells but were small compared to the larger and more numerous inclusions seen with mutant protein (25-60% of cells; see also Fig. 6B for quantitative analysis).",
          "judgment": "Yes",
          "reasoning": "The paper included negative (wild-type) controls. Multiple replicates were used, as stated in figure legends and methods: 'Four replicate transfections were used, with at least 50 cells counted per culture.'",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants R1441C, Y1699C, G2019S and I2020T as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Not applicable here",
          "judgment": "No",
          "reasoning": "The paper does not provide OddsPath calculations or sufficient statistical analysis to derive OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper used R1441C, Y1699C, G2019S, and I2020T as controls. Cell counts were performed and statistical significance was evaluated, indicating multiple data points across replicates, though not statistically combined into an OddsPath.",
          "judgment": "N/A",
          "reasoning": "Since the number of benign/pathogenic variants used in the study as controls is more than 11 (R1441C, Y1699C, G2019S, I2020T, kinase-dead variants, etc.)",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The LRRK2 Y1699C variant increases inclusion body formation and causes cell death, which is related to the disease mechanism of Parkinson's disease. The number of controls is > 10. Therefore, a moderate strength of evidence is assigned."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD). Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain. However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations. In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that mutations in LRRK2 cause PD, leading to increased inclusion body formation and cell death, defining the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used, inclusion body formation and cell death assays, are relevant to the defined disease mechanism of PD caused by LRRK2 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells (Fig. 2A). Wild-type dardarin formed inclusion bodies in approximately 5% of cells but were small compared to the larger and more numerous inclusions seen with mutant protein (25-60% of cells; see also Fig. 6B for quantitative analysis).",
          "judgment": "Yes",
          "reasoning": "The paper included negative (wild-type) controls. Multiple replicates were used, as stated in figure legends and methods: 'Four replicate transfections were used, with at least 50 cells counted per culture.'",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants R1441C, Y1699C, G2019S and I2020T as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Not applicable here",
          "judgment": "No",
          "reasoning": "The paper does not provide OddsPath calculations or sufficient statistical analysis to derive OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper used R1441C, Y1699C, G2019S, and I2020T as controls. Cell counts were performed and statistical significance was evaluated, indicating multiple data points across replicates, though not statistically combined into an OddsPath.",
          "judgment": "N/A",
          "reasoning": "Since the number of benign/pathogenic variants used in the study as controls is more than 11 (R1441C, Y1699C, G2019S, I2020T, kinase-dead variants, etc.)",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The LRRK2 G2019S variant increases inclusion body formation which is related to the disease mechanism of Parkinson's disease. The number of controls is > 10. Therefore, a moderate strength of evidence is assigned."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD). Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain. However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations. In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that mutations in LRRK2 cause PD, leading to increased inclusion body formation and cell death, defining the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In this study, we noted two cellular phenotypes associated with mutant dardarin. First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies. Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.",
          "judgment": "Yes",
          "reasoning": "The assays used, inclusion body formation and cell death assays, are relevant to the defined disease mechanism of PD caused by LRRK2 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells (Fig. 2A). Wild-type dardarin formed inclusion bodies in approximately 5% of cells but were small compared to the larger and more numerous inclusions seen with mutant protein (25-60% of cells; see also Fig. 6B for quantitative analysis).",
          "judgment": "Yes",
          "reasoning": "The paper included negative (wild-type) controls. Multiple replicates were used, as stated in figure legends and methods: 'Four replicate transfections were used, with at least 50 cells counted per culture.'",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "For example, R1441C and Y1699C formed larger inclusion bodies within the cytoplasm in a majority of cells, whereas G2019S or I2020T formed more focused perinuclear inclusion bodies in a smaller, but still appreciable, proportion of cells",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants R1441C, Y1699C, G2019S and I2020T as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Not applicable here",
          "judgment": "No",
          "reasoning": "The paper does not provide OddsPath calculations or sufficient statistical analysis to derive OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper used R1441C, Y1699C, G2019S, and I2020T as controls. Cell counts were performed and statistical significance was evaluated, indicating multiple data points across replicates, though not statistically combined into an OddsPath.",
          "judgment": "N/A",
          "reasoning": "Since the number of benign/pathogenic variants used in the study as controls is more than 11 (R1441C, Y1699C, G2019S, I2020T, kinase-dead variants, etc.)",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The LRRK2 I2020T variant increases inclusion body formation which is related to the disease mechanism of Parkinson's disease. The number of controls is > 10. Therefore, a moderate strength of evidence is assigned."
    }
  ]
}
